COMPOSITION | |
---|---|
Esomeprazole | 40MG |
Levosulpiride | 75MG |
Esomeprazole Levosulpiride
ESOVIB L
SPECIFICATION | |
---|---|
FORM | CAPSULE |
PACKING | 10×10 |
PACKING TYPE | ALU ALU |
MRP | 1700 |
DESCRIPTION
A highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers and zollinger-ellison syndrome. The drug inhibits the H(+)-K(+)-ATPase (H(+)-K(+)-exchanging ATPase) in the proton pump of gastric parietal cells. [PubChem]
SIDE EFFECTS
Blurred vision, confusion, drowsiness, dry mouth, flushing headache, nausea, rapid heartbeat, sweating
INDICATION
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use.